Clinical features of neuroendocrine prostate cancer

BACKGROUND: Neuroendocrine prostate cancer (NEPC) is an aggressive variant of prostate cancer that may arise de novo or in patients previously treated with hormonal therapies for prostate adenocarcinoma as a mechanism of resistance. Despite being important to recognise, the clinical features of NEPC...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Cancer
Autori principali: Conteduca, Vincenza, Oromendia, Clara, Eng, Kenneth W., Bareja, Rohan, Sigouros, Michael, Molina, Ana, Faltas, Bishoy M., Sboner, Andrea, Mosquera, Juan Miguel, Elemento, Olivier, Nanus, David M., Tagawa, Scott T., Ballman, Karla V., Beltran, Himisha
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6803064/
https://ncbi.nlm.nih.gov/pubmed/31525487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2019.08.011
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi